Public Hearing Draws Criticism Over Nebraska Medical Cannabis Regulations
A recent public hearing held by the Nebraska Medical Cannabis Commission witnessed a wave of discontent from advocates who believe the commission is imposing excessive restrictions. Present at the meeting was Lia Post, who voiced her concerns.
“Stopping the will of the people, stopping the freedom of full plant use, stopping the freedom of choice of how I best use my medications, that is the legacy of the Nebraska Medical Cannabis Commission,” Post expressed.
The regulations under scrutiny include limitations on which parts of the marijuana plant can be used, caps on THC levels, and licensure requirements for doctors prescribing cannabis as a treatment. These measures have been criticized by medical marijuana proponents as overly burdensome, with additional worries about the lack of patient privacy safeguards.
Angela Cornett, an advocate for medical cannabis, argued that the current framework deviates from the intent of the law approved by Nebraska voters in 2024, potentially hindering doctors’ ability to serve their patients effectively.
“Overregulation will prevent doctors from being able to meet their patients’ specific needs,” Cornett stated.
The meeting concluded without any immediate action from the commissioners. The commission will reconvene on March 16.
